Search

The article announces the U.S. Food & Drug Administration approval of Pyzchiva (ustekinumab-ttwe) as a biosimilar to Stelara, set to be marketed by Sandoz starting February 22, 2025. It also discusses Pyzchiva's availability in subcutaneous and intravenous forms, its approval for treating various conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis, and its potential interchangeability.

The article focuses on the potential use of Traditional Chinese Medicine (TCM) for treating psoriatic skin. Topics include the properties of honeysuckle, Rehmannia glutinosa and rhubarb can treat Psoriasis, a chronic, inflammatory and hyperproliferative mediated skin disease, as herbal dermocosmetics can influence pathogenic mechanisms through antiinflammatory and anti-angiogenic effects.

The article offers insights on the common skin disorder psoriasis in 2024. Topics covered include its root in the physiological immune system wherein skin cells multiply faster than normal leading to itchy and painful plaques, and the condition's interference in an affected person's life and relationships. Also noted are coping strategies for psoriasis like involving family members in treatment, consulting a dermatologist, and keeping up to date on available treatments.

Heavy drinkers who took the drug consumed less alcohol than those given a placebo [ABSTRACT FROM AUTHOR]

The article offers information on the products derived from cannabis focusing on the benefits of this medicinal plant. It mentions that with legalization of marijuana marketing professionals and business enterprises are trying to achieve the plant's full potential in its products. The benefits such as treating skin conditions such as psoriasis and eczema. The article also presents interview with marijuana grower Johanna Mortz. The article evaluates soap and massage oil made with Cannabidiol.

The article discusses the chemical components of hemp and marijuana, which are both derived from cannabis sativa, and its holistic healing benefits for skin diseases including psoriasis, acne, and blemish.

The article focuses on taking care of the skin through variety of skincare products, impact on skin due to ageing, and protection from skin cancer. It discusses choosing moisturisers according to the skin type, identifying eczema by knowing symptoms, curing eczema through natural therapies. It also looks at reasons and conditions of psoriasis and rosacea.

The article offers information on corneotherapy, which refers to therapeutic interventions aimed at repairing stratum corneum barriers impaired through skin disorders like atopic dermatitis and psoriasis, and mentions functions of stratum corneum.

The article offers information on the causes, prevention and treatment of psoriasis, a common skin condition that affects the lifecycle of skin cells.

An anonymous 9-question survey was composed and distributed to members of the Texas Dermatological Society to evaluate dermatologists' prescription of commercial tanning beds for treatment of certain dermatologic and other medical conditions and to seek opinions on whether commercial tanning beds are a legitimate medical therapy. Results show that although dermatologists agree recreational tanning should always be discouraged, some Texas dermatologists do occasionally recommend commercial tanning bed use for some conditions in patients who cannot afford traditional inoffice phototherapy because they lack insurance or have high copays or for those patients who live in regions with limited access to in-office phototherapy or have significant barriers to coming into the clinic. Conditions for which patients are referred to commercial tanning beds include psoriasis, renal prurigo, atopic dermatitis, and mycosis fungoides. [ABSTRACT FROM AUTHOR]

The article presents several facts about psoriasis, particularly its recommended medications and other standard therapies. According to Massachusetts General Hospital's Doctor Flavia Fedeles, there is no cure for the condition but there are some strategies to reduce flare-ups and manage severity. Among the common strategies are topical medications like ointments and lotions, phototherapy, and biologic therapy.

Abnormal epidermal turnover in psoriatic skin impairs its barrier function and tissue repair capabilities. Therefore, studies of hyperkeratinization and hyperproliferation have been conducted to better understand the disease. Here, the administration of heavy water and a tape stripping method are used to measure skin protein turnover in psoriatic skin and surrounding tissues. Results demonstrate benefits over other proliferation measurements. [ABSTRACT FROM AUTHOR]

The article offers information on several drugs for the treatment of skin diseases. The Acanya lincosamide antibiotic from phamaceutical firm Coria Laboratories Ltd. is designed for the treatment of acne vulgaris. The adverse reactions of the Aldara immune response modifier for the treatment of actinic keratoses on face or scalp include erythema and flaking. Patients using the Dovonex cream for their psoriasis are advised to stop using the product if irritation or hypercalcemia occurs.

The article offers information on natural body therapies such as dry brush exfoliation, salt scrubs and mud treatment that not only medicinal solutions but also offers esthetic benefits. Topics discussed include removal of dead skin cells stimulating blood and lymph flow through detoxication process, treatment of psoriasis and eczema by salt scrubs containing magnesium and hydration of skin through the mud treatment reducing skin roughness.

The article offers information on several drugs for treatment of dermatological disorders. It states that one should avoid interaction of Acanya from the company Coria used in treatment of acne vulgaris with erythromycin. It mentions that side effects of Zyclara from Medicis Pharmaceutical Corp. includes inflammation, dryness and chest pain. It highlights that Dovonex Cream from Leo Pharma Inc. is used in treatment of plaque psoriasis.

The article profiles the Biocon Inc.'s novel anti-psoriasis biotechnology drug, Alzumab, a recipient of BioSpectrum's Biopharma Product of the Year award. The drug is believed to be the world's first molecule targeting a novel CD6 antigen to treat autoimmune diseases. It went through one-of-the-largest clinical trials for biological drug in India, and reveals that 46% of respondents achieved at least 75% improvement in their psoriasis.

The article reports on a consensus of treatment goals for patients with moderate to severe psoriasis which was developed in Australia as a result of an alliance was formed between the Skin & Cancer Foundation Inc. and a multidisciplinary panel of health care professionals from across the country. A discussion of a European consensus initiative on the treatment of psoriasis which was established in 2009 is presented.

An excerpt from the paper "Placebo Response in Relation to Clinical Trial Design: Systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment," by Sonia Lamel and others in the "Archives of Dermatological Research" is presented.

The article presents information on the LEO Quality Care program launched by LEO Pharma Inc. for the patients suffering from plaque psoriasis. It states that the treatment program is a combination of the Taclonex ointment and the Taclonex Scalp topical suspension. It further informs about the main features of the program and also focuses on its usage instructions.

The article presents several drug prescriptions for psoriasis. It states that Rid Lice Killing No-Drip Mousse from Bayer Consumer Care AG can be used by adults through applying to dry area until thoroughly wet with product. It says that Enbrel or tumor necrosis factor (TNF) blocker from Amgen Inc. interacts with concurrent cyclophosphamide. It adds that Neoral from Novartis AG is not recommended for use in children.

The article offers information on topical steroid drugs for the treatment of dermatologic disorders. It mentions that low to intermediate potency steroids are indicated for skin disorders including dermatitis, eczema, chronic lichen simplex, pruritus, and psoriasis, while higher potency products are indicated for psoriasis of palms, soles, elbows, and knees. In addition, the contraindications, precautions, and adverse reactions of the drugs are presented.

A personal narrative is presented which explores the author's experience of having treated a patient with psoriasis through homeopathy.

The article presents a study regarding the clinical efficiency and cost-effectiveness of treatments for moderate to severe psoriasis based on the perspective of a managed health care system. The study determined randomized trials of psoriasis treatment through a MEDLINE search. It used the Psoriasis Area and Severity Index (PASI) to measure the treatment efficacy of psoriasis and that it estimated cost-effectiveness as the sum of total annucalized cost divided by treatment efficacy.

The article offers an overview of several drugs for dermatological disorders including benzamycin pak and cleocin for acne, mycostatin cream and lamisil solution for skin infections, and dovonex cream and olux for psoriasis. It highlights the indications, contraindications, precautions, and adverse reactions of the drugs. It also presents a chart which depicts the classification of topical steroid preparations by potency.

Cold weather can hamper your skin's ability to produce and maintain moisture, which can turn an otherwise healthy scalp into an arid environment come deep winter.THE TREATMENT"Grab an antiyeast, antifungal shampoo that contains selenium sulfide or zinc pyrithione", says Dr. Kleinfelder. LIFE GROOMING HT

This article reports on biologic drugs for psoriasis treatment. It discusses that more dermatologists are prescribing biologics for their patients who have psoriasis and some biologics are injectables that can be administered at home which are typically covered under the health plan's pharmacy benefit.

The article presents updates on various therapeutic research. A study found that omega-3 fatty acids reduce diastolic blood pressure and increase factor VII in patients with type 2 diabetes mellitus. Researchers concluded that methylphenidate, but not aripiprazole, appears to be effective in the treatment of patients with amphetamine dependence. U.S. researchers reported that continuous therapy with infliximab for the treatment of plaque psoriasis is more effective than intermittent therapy.

The article provides information on individualized treatment for childhood psoriasis. According to the article, psoriasis in childhood manifests in many forms and may change over time and that the disease can develop at any age. Predisposing genetic influences of the disease include association with certain human leukocyte antigens. The use of topical corticosteroids for treatment can be effective but a rebound flare of psoriasis often occurs when a potent steroid is discontinued. The only approved topical retinoid for the treatment of psoriasis is Tazarotene which is available as gel or cream.

Discusses the effectiveness and cost of biologic agents developed for the treatment of psoriasis. Goal of each bioengineered agents developed to help induce and maintain the remission of psoriasis; Side effects; Risks, benefits, mechanism of action, administration and FDA drug approval status of these biologic agents, namely, alefacept, efalizumab, etanercept, infliximab and adalimumab.

Provides an overview of several studies related to therapeutics. Function of sertraline in improving mood and physical symptoms in women with premenstrual syndrome; Effectiveness of etanercept therapy in the treatment of psoriasis; Options for sequential therapy in proliferative lupus nephritis.

Provides an overview of several studies related to therapeutics. Feasibility of intracoronary infusion of granulocyte colony-stimulating factor mobilized cells; Effectiveness of oral tazarotene in the treatment of psoriasis; Comparison of the effectiveness of omapatrilat and enalapril in the treatment of hypertensive patients.

Presents a selection of drug products. Complete care for psoriasis; Hair and scalp treatment products; Drug for treatment of baldness.

The article focuses on the "Doctor Fish of Kangal" in Kangal, Turkey. The fish, which are a part of the carp and minnow family, live in a hot spring located near Kangal. The spring was walled off from a nearby creek where the fish originated. The hot spring is too hot to sustain enough algae and plankton to feed them all. The fish nibble dead skin off of bathers, feeding off the skin to survive. A Turkish family constructed a hotel and markets the resort to psoriasis patients.

Reports on new medications to treat skin diseases. Discovery that many skin diseases are due to overactive or underactive immune systems; Efalizumab which treats psoriasis; A cream called imiquimod which treats genital warts, basal cell carcinoma and scars; Fewer side effects and faster action of these new drugs; How each of the drugs works against the disease.

The article focuses on the treatment of skin disease psoriasis. For years biotech firms had tried but failed to develop drugs for psoriasis. Scientists thought it was a skin disease, but in the mid-1980s they realized it is caused by a breakdown in the immune system. In a cruel twist, the body's disease-fighting T cells attack healthy skin cells, misidentifying them as foreign. Psoriatic skin tries to repair itself by generating new cells, but it does so seven times as fast as healthy skin. It is reported that a drug named Amevive, from Biogen Inc., has been effective in the treatment of the disease.

The article focuses on the most common skin problems and presents suggestions on dealing with them. It is noted that psoriasis an inflammatory skin condition characterized by skin cells growing too quickly and can happen when the skin's immune system reacts to things like trauma, stress and infection. It is advised to avoid salon treatments that involves steam if having acne.

Presents brief articles on home remedies. Easing poison ivy with the common weed, jewelweed; Soothing psoriasis with sunlight; Alleviating stiff joints with hot sauce.

Discusses the psoriasis skin disorder, new treatments available and how to avoid flare-ups. Advice to prevent attacks; Stress and psoriasis; Medically approved medications; Experimental medications such as vitamin D3, fish oil and acitretin, a vitamin A derivative; Results of studies conducted at the vitamin D laboratory at Boston City Hospital and the Skin Research Foundation of California.

The article looks at some important issues to put in mind when it comes to psoriasis, including appearance, location, prevention, and treatment. Assistant dermatology professor Dr. Gideon Smith said psoriasis is among the most common skin conditions that affect 2 percent of the U.S. population. Plaque psoriasis is marked by patches on the trunk and limbs. A 2017 study in the "American Journal of Clinical Dermatology" found that severe psoriasis strikes more men than women.

The article presents questions and answers related to medical topics including how to treat psoriasis in nails, which patients with fungal nail infections should be treated, and what investigations are applicable for patients with clubbing.

The article informs that Idera Pharmaceuticals Inc. has released data from its preclinical studies of IMO-8400. The trial demonstrates a novel mechanism of action that can be used for the treatment of systemic lupus erythematosus (SLE) and psoriasis. IMO-8400 is an inhibitor of specific Toll-like receptors (TLRs). The data were presented at the "American Association of Immunologists (AAI)" meeting held in Boston, Massachusetts on May 4-8, 2012.

The article informs that Provectus Pharmaceuticals Inc. has released the top-line data for its randomized controlled trial on PH-10 for treating plaque psoriasis. It further informs that PH-10 is composed of Rose Bengal disodium which is used for treating atopic dermatitis, eye damage and diagnosis of liver ailments. It mentions that the U.S. Food and Drug Administration has granted the orphan drug designation for its melanoma and hepatocellular carcinoma drugs.

The article focuses on a study performed by Anacor Pharmaceuticals Inc. on the ointment AN2728. According to the results of the preliminary studies, two percent is well tolerated on large body surface and sensitive skin. This ointment can be used on areas susceptible to steroids side effects and shows irritation from vitamin D analogs. It is suggested that, the ointment could be used for the treatment of psoriasis and dermatitis patients.